Consideration of species differences in developing novel molecules as cognition enhancers

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 9, 2013, Pages 2181-2193

  Young, Jared W ^a   Jentsch, J David ^b   Bussey, Timothy J ^c   Wallace, Tanya L ^d   Hutcheson, Daniel M ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UK   (United Kingdom)

^d SRI INTERNATIONAL   (United States)

^e Maccine Pte Ltd   (Singapore)

Author keywords

Attention; CNTRICS; Cognitive; Differences; Human primates; Impulsivity; Mice; Monkeys; Non human primates; Rats; Reversal learning; Species

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CLONIDINE; DOPAMINE 2 RECEPTOR; GUANFACINE; NOOTROPIC AGENT; PLACEBO; TACRINE;

ALZHEIMER DISEASE; ASSOCIATION; ATTENTION DISTURBANCE; COGNITIVE DEFECT; CONSTRUCT VALIDITY; CONVERGENT VALIDITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESEARCH; DRUG SYNTHESIS; FACE VALIDITY; HUMAN; IMPULSIVENESS; LEARNING DISORDER; MENTAL CAPACITY; MENTAL PERFORMANCE; MENTAL TASK; MENTAL TEST; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NONHUMAN; OLFACTORY DISCRIMINATION; PATHOPHYSIOLOGY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOPATHY; RESPONSE TIME; REVIEW; SCHIZOPHRENIA; SENSORY STIMULATION; SPATIAL DISCRIMINATION; SPATIAL MEMORY; SPECIES DIFFERENCE; TRANSLATIONAL VALIDITY; TREATMENT RESPONSE; VALIDATION STUDY; VALIDITY; WORKING MEMORY;

ATTENTION; CNTRICS; COGNITIVE; DIFFERENCES; HUMAN PRIMATES; IMPULSIVITY; MICE; MONKEYS; NON-HUMAN PRIMATES; RATS; REVERSAL LEARNING; SPECIES;

ANIMALS; ASSOCIATION LEARNING; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SPECIES SPECIFICITY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84888840298     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.10.002     Document Type: Review

References (151)

1. Abdul-Monim Z., Reynolds G.P., Neill J.C. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. Journal of Psychopharmacology 2003, 17:57-65.
2. Abraham N.M., Spors H., Carleton A., Margrie T.W., Kuner T., Schaefer A.T. Maintaining accuracy at the expense of speed: stimulus similarity defines odor discrimination time in mice. Neuron 2004, 44:865-876.
3. Arnsten A.F., Lin C.H., Van Dyck C.H., Stanhope K.J. The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys. Neurobiology of Aging 1997, 18:21-28.
4. Balci F., Ludvig E.A., Gibson J.M., Allen B.D., Frank K.M., Kapustinski B.J., Fedolak T.E., Brunner D. Pharmacological manipulations of interval timing using the peak procedure in male C3H mice. Psychopharmacology (Berl) 2008, 201:67-80.
5. Bari A., Theobald D.E., Caprioli D., Mar A.C., Aidoo-Micah A., Dalley J.W., Robbins T.W. Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology 2010, 35:1290-1301.
6. Barkus C., Feyder M., Graybeal C., Wright T., Wiedholz L., Izquierdo A., Kiselycznyk C., Schmitt W., Sanderson D.J., Rawlins J.N., Saksida L.M., Bussey T.J., Sprengel R., Bannerman D., Holmes A. Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder?. Neuropharmacology 2011, 62(3):1263-1272.
7. Barnes S.A., Young J.W., Neill J.C. D(1) receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test. Psychopharmacology (Berl) 2011, 220(1):129-141.
8. Barnes S.A., Young J.W., Neill J.C. Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased. Neuropharmacology 2011, 62(3):1432-1441.
9. Barnet R.A., Graheme N.J., Miller R.R. Trial spacing effects in Pavlovian conditioning: a role for local context. Animal Learning and Behavior 1995, 23:340-348.
10. Barnett J.H., Robbins T.W., Leeson V.C., Sahakian B.J., Joyce E.M., Blackwell A.D. Assessing cognitive function in clinical trials of schizophrenia. Neuroscience and Biobehavioral Reviews 2010, 34:1161-1177.
11. Barnett J.H., Sahakian B.J., Werners U., Hill K.E., Brazil R., Gallagher O., Bullmore E.T., Jones P.B. Visuospatial learning and executive function are independently impaired in first-episode psychosis. Psychological Medicine 2005, 35:1031-1041.
12. Bartko S.J., Romberg C., White B., Wess J., Bussey T.J., Saksida L.M. Intact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method. Neuropharmacology 2011, 61:1366-1378.
13. Bartko S.J., Vendrell I., Saksida L.M., Bussey T.J. A computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil. Psychopharmacology 2011, 214:537-548.
14. Bartok E., Berecz R., Glaub T., Degrell I. Cognitive functions in prepsychotic patients. Progress in Neuro-psychopharmacology and Biological Psychiatry 2005, 29:621-625.
15. Benowitz N.L., Jacob P. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clinical Pharmacology and Therapeutics 1994, 56:483-493.
16. Birrell J.M., Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. Journal of Neuroscience 2000, 20:4320-4324.
17. Bissonette G.B., Martins G.J., Franz T.M., Harper E.S., Schoenbaum G., Powell E.M. Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. Journal of Neuroscience 2008, 28:11124-11130.
18. Blackwell A.D., Sahakian B.J., Vesey R., Semple J.M., Robbins T.W., Hodges J.R. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2004, 17:42-48.
19. Body S., Cheung T.H., Hampson C.L., den Boon F.S., Bezzina G., Fone K.C., Bradshaw C.M., Szabadi E. Attenuation of the effects of d-amphetamine on interval timing behavior by central 5-hydroxytryptamine depletion. Psychopharmacology (Berl) 2009, 203:547-559.
20. Bodyak N., Slotnick B. Performance of mice in an automated olfactometer: odor detection, discrimination and odor memory. Chemical Senses 1999, 24:637-645.
21. Boulougouris V., Castane A., Robbins T.W. Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior. Psychopharmacology (Berl) 2008, 202(4):611-620.
22. Boulougouris V., Dalley J.W., Robbins T.W. Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behavioural Brain Research 2007, 179:219-228.
23. Boulougouris V., Robbins T.W. Pre-surgical training ameliorates orbitofrontal-mediated impairments in spatial reversal learning. Behavioural Brain Research 2009, 197(2):469-475.
24. Brigman J.L., Mathur P., Harvey-White J., Izquierdo A., Saksida L.M., Bussey T.J., Fox S., Deneris E., Murphy D.L., Holmes A. Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cerebral Cortex 2010, 20:1955-1963.
25. Bussey T.J., Everitt B.J., Robbins T.W. Dissociable effects of cingulate and medial frontal cortex lesions on stimulus-reward learning using a novel Pavlovian autoshaping procedure for the rat: implications for the neurobiology of emotion. Behavioral Neuroscience 1997, 111:908-919.
26. Bussey T.J., Holmes A., Lyon L., Mar A.C., McAllister K.A., Nithianantharajah J., Oomen C.A., Saksida L.M. New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats. Neuropharmacology 2011, 62(3):1191-1203.
27. Bussey T.J., Muir J.L., Robbins T.W. A novel automated touchscreen procedure for assessing learning in the rat using computer graphic stimuli. Neuroscience Research Communications 1994, 15:103-110.
28. Bussey T.J., Saksida L.M., Rothblat L.A. Discrimination of computer-graphic stimuli by mice: a method for the behavioral characterization of transgenic and gene-knockout models. Behavioral Neuroscience 2001, 115:957-960.
29. Butters N., Butter C., Rosen J., Stein D. Behavioral effects of sequential and one-stage ablations of orbital prefrontal cortex in the monkey. Experimental Neurology 1973, 39:204-214.
30. Carli M., Robbins T.W., Evenden J.L., Everitt B.J. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behavioural Brain Research 1983, 9:361-380.
31. Castane A., Theobald D.E., Robbins T.W. Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats. Behavioural Brain Research 2010, 210:74-83.
32. Chouinard S., Stip E., Poulin J., Melun J.P., Godbout R., Guillem F., Cohen H. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Current Medical Research and Opinion 2007, 23:575-583.
33. Chudasama Y., Robbins T.W. Dissociable contributions of the orbitofrontal and infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: further evidence for the functional heterogeneity of the rodent frontal cortex. Journal of Neuroscience 2003, 23:8771-8780.
34. Clark L., Cools R., Robbins T.W. The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain and Cognition 2004, 55:41-53.
35. Clarke H.F., Dalley J.W., Crofts H.S., Robbins T.W., Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion. Science 2004, 304:878-880.
36. Clarke H.F., Walker S.C., Crofts H.S., Dalley J.W., Robbins T.W., Roberts A.C. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. Journal of Neuroscience 2005, 25:532-538.
37. Clarke H.F., Walker S.C., Dalley J.W., Robbins T.W., Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cerebral Cortex 2007, 17:18-27.
38. Clelland C.D., Choi M., Romberg C., Clemenson G.D., Fragniere A., Tyers P., Jessberger S., Saksida L.M., Barker R.A., Gage F.H., Bussey T.J. A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science 2009, 325:210-213.
39. Cools R., Clark L., Owen A.M., Robbins T.W. Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. Journal of Neuroscience 2002, 22:4563-4567.
40. Coull J.T., Frith C.D., Dolan R.J., Frackowiak R.S., Grasby P.M. The neural correlates of the noradrenergic modulation of human attention, arousal and learning. European Journal of Neuroscience 1997, 9:589-598.
41. Coull J.T., Middleton H.C., Robbins T.W., Sahakian B.J. Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology (Berl) 1995, 120:322-332.
42. Crawley J. What's Wrong with My Mouse 2007, Wily-Liss, New York.
43. Creer D.J., Romberg C., Saksida L.M., van Praag H., Bussey T.J. Running enhances spatial pattern separation in mice. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:2367-2372.
44. De Steno D.A., Schmauss C. A role for dopamine D2 receptors in reversal learning. Neuroscience 2009, 162:118-127.
45. Dias R., Robbins T.W., Roberts A.C. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 1996, 380:69-72.
46. Dias R., Robbins T.W., Roberts A.C. Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behavioral Neuroscience 1996, 110:872-886.
47. Didriksen M., Christensen A.V. Differences in performance in three strains of rats in a 5-choice serial reaction time task. Pharmacology & Toxicology 1993, 72:66-68.
48. Dudchenko P.A., Talpos J., Young J., Baxter M.G. Animal models of working memory: a review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia. Neuroscience and Biobehavioral Reviews 2013, 37:2111-2124.
49. Ellenbroek B.A., Cools A.R. Animal models for the negative symptoms of schizophrenia. Behavioural Pharmacology 2000, 11:223-233.
50. Ettlinger G., Ridley R.M. Visual discrimination in the monkey: distinguishing the incorrect response. Neuropsychologia 1975, 13:111-113.
51. Evers E.A., Cools R., Clark L., van der Veen F.M., Jolles J., Sahakian B.J., Robbins T.W. Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology 2005, 30:1138-1147.
52. Fagerlund B., Soholm B., Fink-Jensen A., Lublin H., Glenthoj B.Y. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study. Clinical Neuropharmacology 2007, 30:3-12.
53. Fellows L.K., Farah M.J. Ventromedial frontal cortex mediates affective shifting in humans: evidence from a reversal learning paradigm. Brain 2003, 126:1830-1837.
54. Fellows L.K., Farah M.J. Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans. Cerebral Cortex 2005, 15:58-63.
55. Fletcher P.J., Tampakeras M., Sinyard J., Higgins G.A. Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology 2007, 195:223-234.
56. Fowler K.S., Saling M.M., Conway E.L., Semple J.M., Louis W.J. Computerized neuropsychological tests in the early detection of dementia: prospective findings. Journal of the International Neuropsychological Society 1997, 3:139-146.
57. Fowler S.C., Pinkston J., Vorontsova E. Timing and space usage are disrupted by amphetamine in rats maintained on DRL 24-s and DRL 72-s schedules of reinforcement. Psychopharmacology 2009, 204:213-225.
58. Frith C.D., Dowdy J., Ferrier I.N., Crow T.J. Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine). Psychopharmacology (Berl) 1985, 87:490-493.
59. Gamo N.J., Arnsten A.F. Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders. Behavioral Neuroscience 2011, 125:282-296.
60. Geyer M.A., Braff D., Swerdlow N.R. Startle-response measures of information processing in animals. Animal Models of Human Emotion & Cognition 1999, 103-116. APA Books, Washington, DC. M. Haug, R.E. Whalen (Eds.).
61. Geyer M.A., Braff D.L. Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophrenia Bulletin 1987, 13:643-668.
62. Geyer M.A., Markou A. Animal models of psychiatric disorders. Psychopharmacology: The fourth Generation of Progress 1995, 787-798. Raven Press, New York. F.E. Bloom, D. Kupfer (Eds.).
63. Ghahremani D.G., Monterosso J., Jentsch J.D., Bilder R.M., Poldrack R.A. Neural components underlying behavioral flexibility in human reversal learning. Cerebral Cortex 2010, 20:1843-1852.
64. Greig N.H., Sambamurti K., Yu Q.S., Brossi A., Bruinsma G.B., Lahiri D.K. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Current Alzheimer Research 2005, 2:281-290.
65. Groman S.M., Lee B., London E.D., Mandelkern M.A., James A.S., Feiler K., Rivera R., Dahlbom M., Sossi V., Vandervoort E., Jentsch J.D. Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. Journal of Neuroscience 2011, 31:7291-7299.
66. Haluk D.M., Floresco S.B. Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology 2009, 34:2041-2052.
67. Humby T., Laird F.M., Davies W., Wilkinson L.S. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. European Journal of Neuroscience 1999, 11:2813-2823.
68. Idris N., Neill J., Grayson B., Bang-Andersen B., Witten L.M., Brennum L.T., Arnt J. Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms. Psychopharmacology (Berl) 2010, 208:23-36.
69. Iversen S.D., Mishkin M. Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Experimental Brain Research 1970, 11:376-386.
70. Izquierdo A., Belcher A.M., Scott L., Cazares V.A., Chen J., O'Dell S.J., Malvaez M., Wu T., Marshall J.F. Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine. Neuropsychopharmacology 2010, 35:505-514.
71. Izquierdo A., Murray E.A. Combined unilateral lesions of the amygdala and orbital prefrontal cortex impair affective processing in rhesus monkeys. Journal of Neurophysiology 2004, 91:2023-2039.
72. Izquierdo A., Newman T.K., Higley J.D., Murray E.A. Genetic modulation of cognitive flexibility and socioemotional behavior in rhesus monkeys. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14128-14133.
73. Izquierdo A., Suda R.K., Murray E.A. Bilateral orbital prefrontal cortex lesions in rhesus monkeys disrupt choices guided by both reward value and reward contingency. Journal of Neuroscience 2004, 24:7540-7548.
74. Jakala P., Sirvio J., Riekkinen M., Koivisto E., Kejonen K., Vanhanen M., Riekkinen P. Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans. Neuropsychopharmacology 1999, 20:119-130.
75. Jocham G., Klein T.A., Neumann J., von Cramon D.Y., Reuter M., Ullsperger M. Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. Journal of Neuroscience 2009, 29:3695-3704.
76. Kapur S., Zipursky R., Jones C., Shammi C.S., Remington G., Seeman P. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Archives of General Psychiatry 2000, 57:553-559.
77. Karlsson R.M., Tanaka K., Saksida L.M., Bussey T.J., Heilig M., Holmes A. Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsychopharmacology 2009, 34:1578-1589.
78. Katner S.N., Davis S.A., Kirsten A.J., Taffe M.A. Effects of nicotine and mecamylamine on cognition in rhesus monkeys. Psychopharmacology 2004, 175:225-240.
79. Kola I., Landis J. Can the pharmaceutical industry reduce attrition rates?. Nature Reviews Drug Discovery 2004, 3:711-715.
80. Kruzich P.J., Grandy D.K. Dopamine D2 receptors mediate two-odor discrimination and reversal learning in C57BL/6 mice. BMC Neuroscience 2004, 5:12.
81. Kruzich P.J., Mitchell S.H., Younkin A., Grandy D.K. Dopamine D2 receptors mediate reversal learning in male C57BL/6J mice. Cognitive, Affective & Behavioral Neuroscience 2006, 6:86-90.
82. Laughlin R.E., Grant T.L., Williams R.W., Jentsch J.D. Genetic dissection of behavioral flexibility: reversal learning in mice. Biological Psychiatry 2011, 69:1109-1116.
83. Laughlin R.E., Grant T.L., Williams R.W., Jentsch J.D. Genetic dissection of behavioral flexibility: reversal learning in mice. Biological Psychiatry 2011, 69(11):1109-1116.
84. Lee B., Groman S., London E.D., Jentsch J.D. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology 2007, 32:2125-2134.
85. Leeson V.C., Robbins T.W., Matheson E., Hutton S.B., Ron M.A., Barnes T.R., Joyce E.M. Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biological Psychiatry 2009, 66:586-593.
86. Lieberman J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997, 17:205-229.
87. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) 1995, 122:35-43.
88. Lipska B.K., Weinberger D.R. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:8906-8910.
89. Lipska B.K., Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000, 23:223-239.
90. Loos M., Staal J., Schoffelmeer A.N., Smit A.B., Spijker S., Pattij T. Inhibitory control and response latency differences between C57BL/6J and DBA/2J mice in a Go/No-Go and 5-choice serial reaction time task and strain-specific responsivity to amphetamine. Behavioural Brain Research 2010, 214:216-224.
91. Lustig C., Kozak R., Sarter M., Young J.W., Robbins T.W. CNTRICS final animal model task selection: control of attention. Neuroscience and Biobehavioral Reviews 2013, 37:2099-2110.
92. Matthysse S. Animal models in psychiatric research. Progress in Brain Research 1986, 65:259-270.
93. McAlonan K., Brown V.J. Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behavioural Brain Research 2003, 146:97-103.
94. McCarthy A.D., Owens I.J., Bansal A.T., McTighe S.M., Bussey T.J., Saksida L.M. FK962 and donepezil act synergistically to improve cognition in rats: potential as an add-on therapy for Alzheimer's disease. Pharmacology Biochemistry and Behavior 2011, 98:76-80.
95. McTighe S.M., Mar A.C., Romberg C., Bussey T.J., Saksida L.M. A new touchscreen test of pattern separation: effect of hippocampal lesions. Neuroreport 2009, 20:881-885.
96. Mehta M.A., Swainson R., Ogilvie A.D., Sahakian J., Robbins T.W. Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology 2001, 159:10-20.
97. Miller R.P., Rotenberg K.S., Adir J. Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. Drug Metabolism and Disposition: The Biological Fate of Chemicals 1977, 5:436-443.
98. Mirza N.R., Bright J.L. Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent. Psychopharmacology 2001, 154:8-12.
99. Morton A.J., Skillings E., Bussey T.J., Saksida L.M. Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system. Nature Methods 2006, 3:767.
100. Murray E.A., Gaffan D., Mishkin M. Neural substrates of visual stimulus-stimulus association in rhesus monkeys. Journal of Neuroscience 1993, 13:4549-4561.
101. Owen A.M., Roberts A.C., Polkey C.E., Sahakian B.J., Robbins T.W. Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1991, 29:993-1006.
102. Owen A.M., Sahakian B.J., Semple J., Polkey C.E., Robbins T.W. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1995, 33:1-24.
103. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., McGuire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361:281-288.
104. Parasuraman R. The Attentive Brain 1998, MIT Press, Cambridge.
105. Patel S., Stolerman I.P., Asherson P., Sluyter F. Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task. Behavioural Brain Research 2006, 170:197-203.
106. Pattij T., Janssen M.C., Loos M., Smit A.B., Schoffelmeer A.N., van Gaalen M.M. Strain specificity and cholinergic modulation of visuospatial attention in three inbred mouse strains. Genes, Brain, and Behavior 2007, 6:579-587.
107. Petersen D.R., Norris K.J., Thompson J.A. A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metabolism and Disposition: The Biological Fate of Chemicals 1984, 12:725-731.
108. Rabbitt P., Lowe C. Patterns of cognitive ageing. Psychology Research 2000, 63:308-316.
109. Riccio C.A., Reynolds C.R., Lowe P., Moore J.J. The continuous performance test: a window on the neural substrates for attention?. Archives of Clinical Neuropsychology 2002, 17:235-272.
110. Ridley R.M., Baker H.F., Haystead T.A. Perseverative behaviour after amphetamine; dissociation of response tendency from reward association. Psychopharmacology 1981, 75:283-286.
111. Ridley R.M., Haystead T.A., Baker H.F. An analysis of visual object reversal learning in the marmoset after amphetamine and haloperidol. Pharmacology Biochemistry and Behavior 1981, 14:345-351.
112. Riekkinen M., Soininen H., Riekkinen P., Kuikka J., Laakso M., Helkala E.L., Partanen J., Riekkinen P. Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease. Neuroscience 1998, 83:471-479.
113. Rinberg D., Koulakov A., Gelperin A. Speed-accuracy tradeoff in olfaction. Neuron 2006, 51:351-358.
114. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 2002, 163:362-380.
115. Robbins T.W., Semple J., Kumar R., Truman M.I., Shorter J., Ferraro A., Fox B., McKay G., Matthews K. Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia. Psychopharmacology 1997, 134:95-106.
116. Robinson E.S., Eagle D.M., Mar A.C., Bari A., Banerjee G., Jiang X., Dalley J.W., Robbins T.W. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 2008, 33:1028-1037.
117. Romberg C., Mattson M.P., Mughal M.R., Bussey T.J., Saksida L.M. Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept). Journal of Neuroscience 2011, 31:3500-3507.
118. Rudebeck P.H., Murray E.A. Amygdala and orbitofrontal cortex lesions differentially influence choices during object reversal learning. Journal of Neuroscience 2008, 28:8338-8343.
119. Rudebeck P.H., Murray E.A. Dissociable effects of subtotal lesions within the macaque orbital prefrontal cortex on reward-guided behavior. Journal of Neuroscience 2011, 31:10569-10578.
120. Sahakian B.J., Morris R.G., Evenden J.L., Heald A., Levy R., Philpot M., Robbins T.W. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 1988, 111(Pt. 3):695-718.
121. Schoenbaum G., Nugent S.L., Saddoris M.P., Setlow B. Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations. Neuroreport 2002, 13:885-890.
122. Schoenbaum G., Setlow B., Nugent S.L., Saddoris M.P., Gallagher M. Lesions of orbitofrontal cortex and basolateral amygdala complex disrupt acquisition of odor-guided discriminations and reversals. Learning and Memory 2003, 10:129-140.
123. Schoenbaum G., Shaham Y. The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biological Psychiatry 2008, 63(3):256-262.
124. Seaton M., Kyerematen G.A., Morgan M., Jeszenka E.V., Vesell E.S. Nicotine metabolism in stumptailed macaques, Macaca arctoides. Drug Metabolism and Disposition: The Biological Fate of Chemicals 1991, 19:946-954.
125. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999, 399:A23-A31.
126. Seu E., Lang A., Rivera R.J., Jentsch J.D. Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys. Psychopharmacology 2009, 202(1-3):505-519.
127. Slotnick B. Animal cognition and the rat olfactory system. Trends in Cognitive Sciences 2001, 5:216-222.
128. Slotnick B.M., Risser J.M. Odor memory and odor learning in rats with lesions of the lateral olfactory tract and mediodorsal thalamic nucleus. Brain Research 1990, 529:23-29.
129. Smith A.G., Neill J.C., Costall B. The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset. Pharmacology Biochemistry and Behavior 1999, 63:201-211.
130. Spinelli S., Ballard T., Gatti-McArthur S., Richards G.J., Kapps M., Woltering T., Wichmann J., Stadler H., Feldon J., Pryce C.R. Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys. Psychopharmacology 2005, 179:292-302.
131. Spratt C., Marston H.M., Sharkey J., Kelly J.S. Comparison of rat and mouse attentional performance in the 5-choice serial reaction task. BNA 2000, 17:P49.03.
132. Stip E., Sepehry A.A., Prouteau A., Briand C., Nicole L., Lalonde P., Lesage A. Cognitive discernible factors between schizophrenia and schizoaffective disorder. Brain and Cognition 2005, 59:292-295.
133. Swainson R., Hodges J.R., Galton C.J., Semple J., Michael A., Dunn B.D., Iddon J.L., Robbins T.W., Sahakian B.J. Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dementia and Geriatric Cognitive Disorders 2001, 12:265-280.
134. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archives of General Psychiatry 1994, 51:139-154.
135. Taffe M.A., Weed M.R., Gutierrez T., Davis S.A., Gold L.H. Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys. Psychopharmacology 2002, 160:253-262.
136. Taiminen T., Jaaskelainen S., Ilonen T., Meyer H., Karlsson H., Lauerma H., Leinonen K.M., Wallenius E., Kaljonen A., Salokangas R.K. Habituation of the blink reflex in first-episode schizophrenia, psychotic depression and non-psychotic depression. Schizophrenia Research 2000, 44:69-79.
137. Tait D.S., Brown V.J. Difficulty overcoming learned non-reward during reversal learning in rats with ibotenic acid lesions of orbital prefrontal cortex. Annals of the New York Academy of Sciences 2007, 1121:407-420.
138. Talpos J.C., McTighe S.M., Dias R., Saksida L.M., Bussey T.J. Trial-unique, delayed nonmatching-to-location (TUNL): a novel, highly hippocampus-dependent automated touchscreen test of location memory and pattern separation. Neurobiology of Learning and Memory 2010, 94:341-352.
139. Talpos J.C., Winters B.D., Dias R., Saksida L.M., Bussey T.J. A novel touchscreen-automated paired-associate learning (PAL) task sensitive to pharmacological manipulation of the hippocampus: a translational rodent model of cognitive impairments in neurodegenerative disease. Psychopharmacology 2009, 205:157-168.
140. Uchida N., Mainen Z.F. Speed and accuracy of olfactory discrimination in the rat. Nature Neuroscience 2003, 6:1224-1229.
141. Von Huben S.N., Davis S.A., Lay C.C., Katner S.N., Crean R.D., Taffe M.A. Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys. Psychopharmacology 2006, 188:586-596.
142. Weiner I., Gal G., Rawlins J.N., Feldon J. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity. Behavioural Brain Research 1996, 81:123-133.
143. Wood S.J., Proffitt T., Mahony K., Smith D.J., Buchanan J.A., Brewer W., Stuart G.W., Velakoulis D., McGorry P.D., Pantelis C. Visuospatial memory and learning in first-episode schizophreniform psychosis and established schizophrenia: a functional correlate of hippocampal pathology?. Psychological Medicine 2002, 32:429-438.
144. Wooters T.E., Bardo M.T. Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in Spontaneously Hypertensive, Wistar-Kyoto and Sprague-Dawley rats. Brain Research 2011, 1396:45-53.
145. Yan T.C., Dudley J.A., Weir R.K., Grabowska E.M., Pena-Oliver Y., Ripley T.L., Hunt S.P., Stephens D.N., Stanford S.C. Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day. PLoS One 2011, 6:e17586.
146. Young J.W., Finlayson K., Spratt C., Marston H.M., Crawford N., Kelly J.S., Sharkey J. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 2004, 29:891-900.
147. Young J.W., Geyer M.A. Action of modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors?. Biological Psychiatry 2010, 67:784-787.
148. Young J.W., Light G.A., Marston H.M., Sharp R., Geyer M.A. The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. PLoS One 2009, 4:e4227.
149. Young J.W., Powell S.B., Risbrough V., Marston H.M., Geyer M.A. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacology & Therapeutics 2009, 122:150-202.
150. Young J.W., Powell S.B., Scott C.N., Zhou X., Geyer M.A. The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: separating response inhibition from premature responding. Behavioural Brain Research 2011, 222:183-192.
151. Young J.W., Powell S.B., Geyer M.A. Mouse pharmacological models of cognitive disruption relevant to schizophrenia. Neuropharmacology 2012, 62(3):1381-1390.